The state Department of Health today notified all vaccine providers to temporarily stop administering doses of the Johnson & Johnson (Janssen) vaccine until at least April 20.
The stoppage is due to Centers for Disease Control and the U.S. Food and Drug Administration guidance. The agencies are reviewing six incidents of rare blood clots that occurred within two weeks of receiving the Johnson & Johnson/Janssen vaccine. All cases occurred in women between 18 and 48 who were among the 6.8 million Americans who received the Johnson & Johnson vaccine, which means less than 1 in 1 million individuals have been affected. The Pfizer and Moderna vaccines are not impacted.
More than 2.4 million Pennsylvanians are now fully vaccinated, and an additional 1.8 million Pennsylvanians have received the first dose of a two-dose vaccine series. Nationally, more than 75 million people have been fully vaccinated. According to the Centers for Disease Control, Pennsylvania has moved up to 19th for total doses administered per capita. Click here for state numbers and here for national numbers.